These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

568 related items for PubMed ID: 29161013

  • 21. Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity.
    Teymouri M, Badiee A, Golmohammadzadeh S, Sadri K, Akhtari J, Mellat M, Nikpoor AR, Jaafari MR.
    Int J Pharm; 2016 Sep 10; 511(1):236-244. PubMed ID: 27363937
    [Abstract] [Full Text] [Related]

  • 22. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.
    Kim MS, Lee DW, Park K, Park SJ, Choi EJ, Park ES, Kim HR.
    Colloids Surf B Biointerfaces; 2014 Apr 01; 116():17-25. PubMed ID: 24441178
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Targeted glioma chemotherapy by cyclic RGD peptide-functionalized reversibly core-crosslinked multifunctional poly(ethylene glycol)-b-poly(ε-caprolactone) micelles.
    Fang Y, Jiang Y, Zou Y, Meng F, Zhang J, Deng C, Sun H, Zhong Z.
    Acta Biomater; 2017 Mar 01; 50():396-406. PubMed ID: 28065871
    [Abstract] [Full Text] [Related]

  • 25. Enhanced small interfering RNA delivery into cells by exploiting the additive effect between photo-sensitive peptides and targeting ligands.
    Lin W, Xie X, Yang Y, Liu H, Fu X, Chen Y, Liu H, Yang Y.
    J Pharm Pharmacol; 2015 Sep 01; 67(9):1215-31. PubMed ID: 25880614
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Enhancing cellular uptake of activable cell-penetrating peptide-doxorubicin conjugate by enzymatic cleavage.
    Shi NQ, Gao W, Xiang B, Qi XR.
    Int J Nanomedicine; 2012 Sep 01; 7():1613-21. PubMed ID: 22619516
    [Abstract] [Full Text] [Related]

  • 32. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
    Belhadj Z, Ying M, Cao X, Hu X, Zhan C, Wei X, Gao J, Wang X, Yan Z, Lu W.
    J Control Release; 2017 Jun 10; 255():132-141. PubMed ID: 28390902
    [Abstract] [Full Text] [Related]

  • 33. Matrix Metalloproteinase-Responsive Multifunctional Peptide-Linked Amphiphilic Block Copolymers for Intelligent Systemic Anticancer Drug Delivery.
    Ke W, Zha Z, Mukerabigwi JF, Chen W, Wang Y, He C, Ge Z.
    Bioconjug Chem; 2017 Aug 16; 28(8):2190-2198. PubMed ID: 28661654
    [Abstract] [Full Text] [Related]

  • 34. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S, Li M, Tang Z, Song W, Sun H, Liu H, Chen X.
    Acta Biomater; 2013 Dec 16; 9(12):9330-42. PubMed ID: 23958784
    [Abstract] [Full Text] [Related]

  • 35. A comprehensive study of iRGD-modified liposomes with improved chemotherapeutic efficacy on B16 melanoma.
    Dai W, Fan Y, Zhang H, Wang X, Zhang Q, Wang X.
    Drug Deliv; 2015 Jan 16; 22(1):10-20. PubMed ID: 24735248
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma.
    Yuan M, Qiu Y, Zhang L, Gao H, He Q.
    Drug Deliv; 2016 May 16; 23(4):1171-83. PubMed ID: 26036724
    [Abstract] [Full Text] [Related]

  • 38. Enhanced antitumor and anti-metastasis efficiency via combined treatment with CXCR4 antagonist and liposomal doxorubicin.
    Mei L, Liu Y, Zhang Q, Gao H, Zhang Z, He Q.
    J Control Release; 2014 Dec 28; 196():324-31. PubMed ID: 25450404
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A polymeric nanocarrier with a tumor acidity-activatable arginine-rich (R9) peptide for enhanced drug delivery.
    Zhang L, Jiang C, Zeng F, Zhou H, Li D, He X, Shen S, Yang X, Wang J.
    Biomater Sci; 2020 Apr 15; 8(8):2255-2263. PubMed ID: 32129378
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.